Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sfranzenburg
    Member
    • Mar 2014
    • 28

    #1

    Metagenome Comparisons in MG-RAST

    Hi,

    Often, I see that authors compare different metagenomes from MG-RAST and finally conclude that "Pathway X" is stronger represented in the microbial community A than in community B.

    However, in my opinion, this is a problem for host-associated metagenomes, since these contain also reads from the host organism.
    If in Metagenome A contains 20% of host reads and metagenome B contains only 5% of host reads, basically all bacterial pathways would appear to be enriched in Metagenome B.

    I have this concrete problem, because I want to compare the metagenome of several closely related host-species. But I want to compare only bacterial genes. Host reads range from 50% - 5% in different species (probably correlates with bacterial load in the gut).

    How can I limit my metagenome analysis to bacteria only.

    My thought was to blast my raw reads against all NCBI bacterial genomes and proceed only with reads that had a hit, but this is too computational demanding?
    How to people do this. Seems like most just ignore the host-read fraction (since for luminal content/feces it is small anyway).

    thanks.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...